Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

NHS Health Check to be digitised to ease GP pressure

US court throws out lawsuits alleging Zantac caused cancer

Investigation launched into alleged animal welfare violations at Neuralink

How eligible patient numbers affect price of rare disease drugs in France

Evidence standard drawn up for digital therapeutics

Antonio Magnelli

65_biotech-center_1100

News/ News/ Press Releases/ R&D/ Views and analysis

Touring Chiesi’s vision for the future at the new Biotech Centre of Excellence

Nicole Raleigh Alberto Chiesi, Antonio Magnelli, biologics, Biotech, Biotech Centre of Excellence, Chiesi, Chiesi Group, Francesca Usberti, Italy, Marcello Catani, Michele Guerra, monoclonal antibodies, Parma, pharma, R&D, Rare diseases, Stefano Bonaccini, Valentino Valentini, Vincenzo Colla 0 Comment

Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure

X

Touring Chiesi’s vision for the future at the new Biotech Centre of Excellence

https://pharmaphorum.com/views-and-analysis/touring-chiesis-vision-for-the-future-at-the-new-biotech-centre-of-excellence/

Science background with molecules and atoms

R&D/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Investing in biologics excellence

Eloise McLennan Antonio Magnelli, biologics, Chiesi Group, Sustainability 0 Comment

In little over three decades, advances in biotechnology have noticeably disrupted the development landscape of small molecule drugs.

X

Investing in biologics excellence

https://pharmaphorum.com/r-d/investing-in-biologics-excellence/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

Elon Musk’s Neuralink brain interface chip set for human trials
GSK cancer division delivers good news after string of R&D setbacks
Pfizer/BioNTech strike back in Moderna COVID vaccine lawsuit
Novartis' Pluvicto presents survival benefit for castration-resistant prostate cancer
New Nkarta data backs up natural killer approach to cancer treatment

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com